R(+)-N-methyl-propargyl-aminoindan

US9339469B2 · kind B2 · utility

Assignee

• TEVA PHARMACEUTICAL INDUSTRIES, LTD. · IL

Inventors

• Muhammad Safadi · Nazareth, IL
• Anton Frenkel · Netanya, IL
• Michal Keisar · Netanya, IL
• Danit Licht · Givat Shmuel, IL
• Eliezer Bahar · Nes Ziona, IL
• Ramy Lidor-Hadas · Kfar Sava, IL
• Marina Zholkovsky · Bat Yam, IL
• Rachel Cohen · Hadera, IL

Key dates

• Filing date: Oct 9, 2012
• Grant date: May 17, 2016
• Expiry date: Jan 12, 2033

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P25/16
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The subject invention provides R(+)-N-methyl-propargyl-aminoindan or a pharmaceutically acceptable salt thereof and a composition containing R(+)-N-propargyl-1(R)-aminoindan or a pharmaceutically acceptable salt thereof, and a compound of R(+)-N-methyl-propargyl-aminoindan or a salt thereof.